J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 76 (1995), 519-527; DOI 10.1099/0022-1317-76-3-519
© 1995 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Poblotzki, A.
Right arrow Articles by Modrow, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Poblotzki, A.
Right arrow Articles by Modrow, S.
Agricola
Right arrow Articles by von Poblotzki, A.
Right arrow Articles by Modrow, S.

Antibodies to parvovirus B19 NS-1 protein in infected individuals

Andreas von Poblotzki1, Andreas Gigler1, Bernhard Lang2, Hans Wolf1 and Susanne Modrow1,*

1 Institut für medizinische Mikrobiologie und Hygiene, Universität Regensburg
and2 Klinik und Poliklinik für Innere Medizin I, Universitätsklinikum Regensburg Franz-Josef-Straubeta-Allee 11, 93053 Regensburg, Germany

Human parvovirus B19 is the aetiological agent of the common childhood disease erythema infectiosum (fifth disease). The infection is usually benign and self-limiting, but in adults cases of severe arthritis which may persist for years have been reported. Neutralizing antibodies directed against the structural proteins are usually produced shortly after the infection. The immune response against the third major protein, the nonstructural protein NS-1, of parvovirus B19 has not been characterized so far. We cloned and expressed the full-length NS-1 protein and fragments thereof in Escherichia coli. The purified recombinant proteins were used to investigate the presence of antibodies to the NS-1 protein in sera from patients with parvovirus B19 infection. Specific antibodies could be detected in sera from patients suffering from severe parvovirus B19-associated arthritis using Western blot analysis and an ELISA. Sera from patients with acute or past infection without complications did not contain detectable levels of immunoglobulin to NS-1. The use of subfragments of the NS-1 protein allowed localization of the antigenic domains in the carboxy-terminal region of the protein.

* Author for correspondence. Fax +49 941 944 6402. e-mail Susanne.modrow@Klinik.regensburg.de

Received 28 September 1994; accepted 11 November 1994.


This article has been cited by other articles:


Home page
J Med MicrobiolHome page
A. Corcoran and S. Doyle
Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19
J. Med. Microbiol., June 1, 2004; 53(6): 459 - 475.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
E. D. Heegaard and K. E. Brown
Human Parvovirus B19
Clin. Microbiol. Rev., July 1, 2002; 15(3): 485 - 505.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Fu, K. K. Ishii, Y. Munakata, T. Saitoh, M. Kaku, and T. Sasaki
Regulation of Tumor Necrosis Factor Alpha Promoter by Human Parvovirus B19 NS1 through Activation of AP-1 and AP-2
J. Virol., May 3, 2002; 76(11): 5395 - 5403.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
L. Kakkola, K. Hedman, H. Vanrobaeys, L. Hedman, and M. Soderlund-Venermo
Cloning and sequencing of TT virus genotype 6 and expression of antigenic open reading frame 2 proteins
J. Gen. Virol., May 1, 2002; 83(5): 979 - 990.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
L. A. MITCHELL, R. LEONG, and K. A. ROSENKE
Lymphocyte recognition of human parvovirus B19 non-structural (NS1) protein: associations with occurrence of acute and chronic arthropathy?
J. Med. Microbiol., July 1, 2001; 50(7): 627 - 635.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J. R Kerr
Pathogenesis of human parvovirus B19 in rheumatic disease
Ann Rheum Dis, September 1, 2000; 59(9): 672 - 683.
[Full Text]


Home page
Rheumatology (Oxford)Home page
J. R. Kerr and V. S. Cunniffe
Antibodies to parvovirus B19 non-structural protein are associated with chronic but not acute arthritis following B19 infection
Rheumatology, August 1, 2000; 39(8): 903 - 908.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
A. HEMAUER, S. MODROW, J. GEORGI, K. HELMKE, P. VAITH, B. LANG, J. SCHÖLMERICH, and R. H STRAUB
There is no association between polymyalgia rheumatica and acute parvovirus B19 infection
Ann Rheum Dis, October 1, 1999; 58(10): 657 - 658.
[Full Text]


Home page
J. Virol.Home page
A. Gigler, S. Dorsch, A. Hemauer, C. Williams, S. Kim, N. S. Young, S. Zolla-Pazner, H. Wolf, M. K. Gorny, and S. Modrow
Generation of Neutralizing Human Monoclonal Antibodies against Parvovirus B19 Proteins
J. Virol., March 1, 1999; 73(3): 1974 - 1979.
[Abstract] [Full Text]


Home page
J. Virol.Home page
R. Gareus, A. Gigler, A. Hemauer, M. Leruez-Ville, F. Morinet, H. Wolf, and S. Modrow
Characterization of cis-Acting and NS1 Protein-Responsive Elements in the p6 Promoter of Parvovirus B19
J. Virol., January 1, 1998; 72(1): 609 - 616.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1995 by the Society for General Microbiology.